Cangene (FRA:YGE) Total Equity : €140.58 Mil (As of Oct. 2013)

View and export this data going back to . Start your Free Trial

What is Cangene Total Equity?

Cangene's total equity for the quarter that ended in Oct. 2013 was €140.58 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Cangene Total Equity Historical Data

The historical data trend for Cangene's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cangene Total Equity Chart

Cangene Annual Data

Trend

Jul04

Jul05

Jul06

Jul07

Jul08

Jul09

Jul10

Jul11

Jul12

Jul13

Total Equity

Get a 7-Day Free Trial

192.80

175.72

156.46

159.02

150.44

Cangene Quarterly Data
	Jan09	Apr09	Jul09	Oct09	Jan10	Apr10	Jul10	Oct10	Jan11	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13
Total Equity	Get a 7-Day Free Trial															154.11	147.89	153.99	150.44	140.58

Cangene Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Cangene's Total Equity for the fiscal year that ended in Jul. 2013 is calculated as

Total Equity	=	Total Assets(Q: Jul. 2013 )	-	Total Liabilities(Q: Jul. 2013 )
	=	218.9	-	68.462
	=	150.44

Cangene's Total Equity for the quarter that ended in Oct. 2013 is calculated as

Total Equity	=	Total Assets(Q: Oct. 2013 )	-	Total Liabilities(Q: Oct. 2013 )
	=	208.847	-	68.269
	=	140.58

Cangene Total Equity Related Terms

Thank you for viewing the detailed overview of Cangene's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Cangene (FRA:YGE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.cangene.com

Cangene Corporation is a fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. The company manages its business and evaluate performance based on two operating segments: biopharmaceutical operations and contract services. Revenues are generated from product sales, and contract manufacturing and contract-R&D services.

Cangene (FRA:YGE) Headlines

No Headlines